Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Polymers (Basel) ; 14(1)2021 Dec 21.
Article in English | MEDLINE | ID: mdl-35012035

ABSTRACT

We present a combination of independent techniques in order to characterize crosslinked elastomers. We combine well-established macroscopic methods, such as rheological and mechanical experiments and equilibrium swelling measurements, a more advanced technique such as proton multiple-quantum NMR, and a new method to measure stress-induced segmental orientation by in situ tensile X-ray scattering. All of these techniques give access to the response of the elastomer network in relation to the crosslinking of the systems. Based on entropic elasticity theory, all these quantities are related to segmental orientation effects through the so-called stress-optical law. By means of the combination of these techniques, we investigate a set of unfilled sulfur-vulcanized styrene butadiene rubber elastomers with different levels of crosslinking. We validate that the results of all methods correlate very well. The relevance of this approach is that it can be applied in any elastomer materials, including materials representative of various industrial application, without prerequisite as regards, e.g., optical transparency or simplified formulation. Moreover, the approach may be used to study reinforcement effects in filled elastomers with nanoparticles.

2.
Blood Purif ; 36(2): 84-91, 2013.
Article in English | MEDLINE | ID: mdl-23989183

ABSTRACT

BACKGROUND: Baxter received reports of visible precipitate, identified as calcium carbonate, forming during hemofiltration with Accusol 35 solution. AIM: To evaluate the potential for acute cardiopulmonary adverse effects of Accusol 35 containing exaggerated calcium carbonate particles. METHODS: Anesthetized dogs underwent continuous veno-venous hemofiltration (CVVH) with Accusol 35 containing visible and subvisible particles (≥10 µm) 36 times higher than the maximum concentration specified in the European Pharmacopoeia (P-Accusol), or Accusol 35 conforming to specification (Accusol). Select cardiovascular and blood gas parameters were evaluated during CVVH. Lung tissue samples were collected following CVVH. RESULTS: No differences were observed in cardiovascular and blood gas parameters or lung histology between P-Accusol and Accusol. CONCLUSION: Accusol 35 containing visible and subvisible particles (≥10 µm) 36 times higher than the maximum concentration specified in the European Pharmacopoeia resulted in no acute cardiopulmonary adverse effects compared with Accusol 35 containing no visible particles and subvisible particles within European Pharmacopoeia specification.


Subject(s)
Calcium Carbonate/chemistry , Heart Injuries/etiology , Hemodialysis Solutions/adverse effects , Hemodialysis Solutions/chemistry , Hemofiltration/adverse effects , Hemofiltration/methods , Lung Injury/etiology , Animals , Crystallization , Dogs , Hydrogen-Ion Concentration , Lung Injury/pathology , Male , Models, Animal , Particle Size
3.
Gastroenterology ; 131(4): 1131-41, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17030183

ABSTRACT

BACKGROUND & AIMS: The G-protein-coupled receptor GPR39 is a member of a family that includes the receptors for ghrelin and motilin. Recently the peptide obestatin was identified as a natural ligand for GPR39. The objective of this study was to gain insight into the biological function of the GPR39 receptor. METHODS: GPR39(-/-) mice were generated and analyzed. RESULTS: Endogenous GPR39 expression was detected in the brain (septum-amygdala) and the gastrointestinal system (parietal cells, enterocytes, neurons, and pancreas). Gastric emptying of a solid meal (measured by the (14)C octanoic breath test) in GPR39(-/-) mice was accelerated significantly with a gastric half-emptying time of 49.5 +/- 2.2 minutes compared with 86.9 +/- 8.4 minutes in GPR39(+/+) mice. A more effective expulsion of distally located pellets (30%-75% of length) was observed in the colon of GPR39(-/-) mice. Four hours after pylorus ligation, the volume of gastric secretion was increased significantly (GPR39(-/-): 638 +/- 336 microL; GPR39(+/+): 225 +/- 170 microL), but gastric acid secretion was unchanged. The mature body weight and body fat composition of GPR39(-/-) mice was significantly higher compared with GPR39(+/+) mice, but this was not related to hyperphagia because 24-hour food intake did not differ between both genotypes. In contrast, deficiency of the GPR39 receptor led to reduced hyperphagia after fasting. The cholesterol levels were increased significantly in the GPR39(-/-) mice. CONCLUSIONS: Our data partially confirm and extend the described in vivo effects of obestatin and suggest that this peptide plays a functional role in the regulation of gastrointestinal and metabolic function through interaction with the GPR39 receptor.


Subject(s)
Peptide Hormones/metabolism , Pylorus/physiology , Receptors, G-Protein-Coupled/genetics , Receptors, G-Protein-Coupled/metabolism , Amino Acid Sequence , Amygdala/physiology , Animals , Body Composition , Body Weight , Caprylates/pharmacokinetics , Carbon Radioisotopes , Cholesterol/blood , Colon/physiology , Eating/physiology , Feces , Gastric Emptying/physiology , Gene Expression , Hydrogen-Ion Concentration , Ligation , Male , Mice , Mice, Knockout , Molecular Sequence Data , Pancreas/physiology , Pylorus/cytology , Pylorus/metabolism , Septum of Brain/physiology
4.
Am J Physiol Gastrointest Liver Physiol ; 289(1): G108-15, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15746214

ABSTRACT

We aimed to evaluate the gastric relaxant capacity of the 5-HT(1/7)-receptor agonist 5-carboxamidotryptamine (5-CT) in conscious dogs and to clarify the mechanism of action by use of selective antagonists, vagotomy, and in vitro experiments. A barostat enabled us to monitor the intragastric volume in response to different treatments (intravenously administered) before and after supradiaphragmatic vagotomy [results presented as the maximum volume change after treatment (mean; n = 5-11)]. In vitro experiments were performed with isolated muscle strips cut from four different stomach regions of the vagotomized dogs [results were fitted to the operational model of agonism to determine the efficacy parameter tau (n = 5)]. 5-CT (0.5-10 microg/kg) caused a dose-dependent gastric relaxation (29-267 ml) that was completely blocked by the selective 5-HT(7)-receptor antagonist SB-269970 (50 microg/kg). After vagotomy, the relaxation to 10 microg/kg 5-CT was significantly less pronounced (73 vs. 267 ml; P < 0.05) but still blocked by SB-269970, whereas the response to the nitric oxide donor nitroprusside was similar to that before vagotomy (178 vs. 218 ml). In vitro, 5-CT concentration dependently inhibited the PGF(2alpha)-contracted muscle strips before and after vagotomy. Although before and after vagotomy the response in every region was mediated by 5-HT(7) receptors (apparent affinity dissociation constant: SB-269970, 8.2-8.6 vs. 8.3-8.6, respectively), the response after vagotomy was less efficacious (log tau: 1.9 to 0.5 vs. 1.4 to -0.1). The results indicate that the 5-CT-induced proximal stomach relaxation in conscious dogs before and after vagotomy is mediated via 5-HT(7) receptors. The decreased efficacy of 5-CT in vitro after vagotomy is probably related to vagotomy-induced changes in receptor density or coupling efficiency and provides a possible explanation for the decreased in vivo response to 5-CT after vagotomy.


Subject(s)
Muscle Relaxation/physiology , Muscle, Smooth/physiology , Receptors, Serotonin/physiology , Serotonin/analogs & derivatives , Stomach/physiology , Animals , Consciousness , Dogs , Female , In Vitro Techniques , Models, Biological , Muscle Relaxation/drug effects , Muscle, Smooth/innervation , Phenols/pharmacology , Serotonin/pharmacology , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Stomach/innervation , Sulfonamides/pharmacology , Vagotomy
5.
Eur J Pharmacol ; 508(1-3): 231-8, 2005 Jan 31.
Article in English | MEDLINE | ID: mdl-15680276

ABSTRACT

Activation of vanilloid receptors has commonly been used to facilitate neurogenic inflammation and plasma exudation to model components of the pathogenesis of migraine; however, these studies have been performed mainly in species lacking the emetic reflex. In the present studies, therefore, we used Suncus murinus, a species of insectivore capable of emesis, to investigate if the vanilloid receptor agonist resiniferatoxin is capable of modeling the emesis associated with migraine. Resiniferatoxin (100 nmol/kg, s.c.) induced an emetic response that was antagonized significantly (P<0.05) by ruthenium red (1-3 micromol), (2R-trans)-4-[1-[3,5-bis(trifluromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-hydroxybutanedioate (R116301; 10-100 micromol/kg), and scopolamine (1 micromol/kg), but not by dihydroergotamine (0.3-3 micromol/kg), sumatriptan (1-10 micromol/kg), methysergide (1-10 micromol/kg), tropanyl 3,5-dichlorobenzoate (MDL72222; 3-30 micromol/kg), ondansetron (0.3-3 micromol/kg), metoclopramide (3-30 micromol/kg), domperidone (3-30 micromol/kg), diphenhydramine (1-10 micromol/kg), or indomethacin (3-30 micromol/kg). The failure of a wide range of representative anti-migraine drugs to reduce retching and vomiting limits the use of this model to identify/investigate novel treatments for the emesis (and nausea) associated with migraine attacks in humans. However, the results provide further evidence for the involvement of a novel vanilloid receptor in resiniferatoxin-induced emesis and implicate both tachykinins and acetylcholine in the pathway(s) activated by resiniferatoxin in S. murinus.


Subject(s)
Antiemetics/pharmacology , Capsaicin/analogs & derivatives , Migraine Disorders/prevention & control , Vomiting/prevention & control , Animals , Butanols/pharmacology , Capsaicin/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Dihydroergotamine/pharmacology , Diphenhydramine/pharmacology , Diterpenes , Domperidone/pharmacology , Dose-Response Relationship, Drug , Drug Evaluation, Preclinical , Humans , Indomethacin/pharmacology , Malates , Methysergide/pharmacology , Metoclopramide/pharmacology , Ondansetron/pharmacology , Piperidines , Ruthenium Red/pharmacology , Scopolamine/pharmacology , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Shrews , Sumatriptan/pharmacology , Time Factors , Tropanes/pharmacology , Vomiting/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...